Dextrose (50%) Injection

[07 November 2016]

Products Affected - Description

All presentations are currently available

Reason for the Shortage

  • Amphastar had 50% dextrose injection on shortage due to increased demand.
  • Hospira had 50% dextrose injection on shortage due to increased demand and manufacturing delays.

Available Products

50% Dextrose intravenous injection, Amphastar
50 mL Luer-Jet syringe, 10 count (NDC 76329-3301-01)
50% Dextrose intravenous injection, Hospira
50 mL LifeShield syringe, 10 count (NDC 00409-4902-34)
50 mL Ansyr II Luer Lock syringe, 10 count (NDC 00409-7517-16)
50 mL vial, 25 count (NDC 00409-6648-02)

Estimated Resupply Dates

All marketed presentations are available.

Related Shortages


November 7, September 27, July 26, June 30 and 3, May 24, 16 and 5, April 7, January 29 and 20, 2016; December 11, November 4, October 8, September 9, August 24, 17 and 4, July 13, June 10, May 21 and 11, April 27, 2015, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
ASHP Product Listing